A reviewer's-eye read on which documentation elements carry a recertification and which ones get skipped.
Adam Gupilan, LVN — Utilization Management
COPD is the diagnosis where the chart most often contradicts the claim. Not because the patient isn't declining — because the fields that get charted (oxygen saturation, "SOB with exertion," a normal-looking weight) are the fields that make a dying patient look stable.
The reviewer is not asking whether the lungs are bad. They are asking whether this period is worse than the last one, and whether the record contains the specific findings that let them say so. Below is what carries and what gets read past.
Skipped: "SpO2 94%." "O2 sat WNL."
Carries: The saturation, the delivery, and the activity state — all three, or none of it counts.
"SpO2 87% at rest on 4L NC, down from 91% on 2L in July. Desaturates to 79% with transfer to bedside commode, recovery to baseline requires ~4 minutes."
Why it matters mechanically: eligibility contemplates hypoxemia while receiving supplemental oxygen. A saturation charted without the flow rate is uninterpretable — it may describe a patient on room air or a patient on 6 liters, and the reviewer cannot assume. Charting the corrected number alone doesn't just fail to help; it puts a normal value in the record that the reviewer has to weigh.
The line most notes omit: the oxygen requirement trend. 2L nocturnal → 3L continuous → 4L continuous is decline stated in a unit nobody argues with, it is already in the chart, and it almost never reaches the narrative.
On ABGs: pCO2 and pO2 rarely exist for a home hospice patient, and their absence is not held against the record. Reviewers substitute pulse oximetry with flow rate. What they cannot substitute for is a saturation with no context.
Skipped: "Shortness of breath with exertion." "Dyspneic on ambulation."
Carries: Dyspnea at rest, quantified, with the response to bronchodilator therapy stated.
"Dyspnea present at rest 6 of 7 days, unchanged after scheduled nebulizer; two rescue nebs/day, up from 0–1 in June. Speaks in 3–4 word phrases, down from full sentences at last recert."
Why it matters: exertional dyspnea is a feature of moderate disease. The construct reviewers work from is dyspnea at rest, poorly responsive to bronchodilators, limiting function. A note that documents exertional dyspnea has documented a patient who still exerts — which reads against the claim, not for it.
Free, specific, almost never charted: the phrase-length observation. Full sentences → short phrases → single words is a graded, reproducible measure of respiratory limitation that requires no equipment.
Skipped: "Hospitalized 7/12 for COPD exacerbation. Discharged 7/16, stable."
Carries: Where the patient landed afterward, relative to where they started.
"Exacerbation 7/12, three days inpatient. Prior to admission: 2L continuous, ambulated to bathroom with walker. Post-discharge and at six weeks: 4L continuous, transfers only with two-person assist. Did not return to pre-exacerbation baseline."
Why it matters: an exacerbation followed by recovery to baseline is a bad month, not a trajectory. Reviewers see plenty of COPD patients who exacerbate several times a year and hold the same functional floor for years. What establishes eligibility is the step down — the failure to recover — and that comparison only exists if someone wrote the pre-exacerbation baseline down.
Also carries: increasing frequency. "Third exacerbation this benefit period; prior period had one." Count and interval, stated plainly.
Skipped: "On prednisone taper." "Completed course of azithromycin."
Carries: The rate.
"Four steroid bursts in the past six months (2/9, 4/2, 6/18, 8/11); one in the preceding six months. Antibiotic courses 3 vs. 1 over the same comparison."
Why it matters: burst frequency is timestamped, quantitative, and already captured in the MAR. It is the COPD analog of a rising diuretic requirement — a treatment escalation that documents worsening disease without requiring anyone to interpret anything. It is also nearly always available and nearly never summarized.
Skipped: "2+ lower extremity edema." "JVD noted."
Carries: The finding attributed to the pulmonary disease.
"Progressive peripheral edema 1+ → 2+ to mid-calf, with JVD and hepatomegaly, in the absence of known left ventricular dysfunction or valvular disease — consistent with cor pulmonale secondary to end-stage COPD."
Why it matters: right heart failure secondary to pulmonary disease supports the terminal COPD picture. Undifferentiated edema does not — it reads as a comorbidity, and on a chart where the patient also carries a cardiac diagnosis it can quietly transfer the decline to a condition that isn't the hospice diagnosis. Attribution is a one-clause fix.
Skipped: "Poor appetite."
Carries: Quantified loss over a stated interval, plus the mechanism if it's respiratory.
"Weight 141 → 128 lbs over five months (9.2%). Stops mid-meal due to dyspnea; intake 35% of meals, down from 60%. Supplements started 6/20, weight continued to fall."
Why it matters: the general rule holds — unintentional loss over a defined window, decline continuing despite intervention. The COPD-specific detail worth adding is why intake dropped. Dyspnea-limited eating ties the nutritional decline back to the terminal diagnosis instead of leaving it floating as a separate problem.
Most end-stage COPD patients cannot perform reliable spirometry, and many hospice charts have no PFT at all. That is expected and does not sink a recertification.
What does hurt: a three-year-old FEV1 cited as though it were current, with no functional data alongside it. It anchors the reviewer on a stale number and substitutes for the evidence that would actually work. If there's no recent PFT, say there's no recent PFT and spend the space on oxygen requirement, rest dyspnea, and function.
A COPD recert note containing these will clear review in most cases:
In CHF, the reviewer's problem is that weight lies. In COPD, it's that oxygen lies.
"SpO2 94%" describes the oxygen. "SpO2 94% on 5L, down from 2L in June" describes the patient.
And the exacerbation was never the evidence — the floor it left behind was.
Written from the utilization management side. No product attached to this — take what's useful.
This series is written one diagnosis at a time, and the useful ones to write next are the ones people are actually losing. If there's a recertification or authorization that keeps coming back on your charts and it isn't covered above, name it and I'll write it up.
No cost, no pitch attached, and nothing patient-specific — the diagnosis and the setting is all I need. If it's a common one, it goes into the series so everyone gets it.
Name a diagnosis →I do utilization review on the payer side, so this is written from the chair the note actually lands in. I also build software for this, at getclinicalflow.com — but nothing above depends on it and there's no obligation attached to asking.
Adam Gupilan, LVN — utilization management. I review the prior authorizations and recertifications that providers submit, which is where everything above comes from.
Nothing here is attached to a product. If it's useful in your charts, use it. More at the full series, or getclinicalflow.com.
Written from the reviewer's side and offered as general documentation guidance. It is not clinical, legal, or billing advice, and it does not reproduce any proprietary criteria text. Eligibility determinations are made by the certifying physician and the reviewing plan.